Name: Belite Bio, Inc (BLTE) Financial Statements
Creator: FinSpry

Belite Bio Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Belite Bio, Inc income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	29.94	24.84	8.87	7.42	3.69
Selling, General & Administrative	10.06	6.82	3.95	2.38	2.06
Operating Expenses	40.00	31.67	12.82	9.80	5.74
Operating Income	-40.00	-31.67	-12.82	-9.80	-5.74
Other Income/Expense
Interest Income	3.74	0.07	0.02	0.01	0.01
Interest Expense	-0.02	-0.03	-0.02	0.00	-0.02
Other Income/Expense	0.14	0.00	0.17	0.13	0.00
Income
Income Before Tax	-36.14	-31.62	-12.65	-9.67	-5.75
Income Tax Expense	0.01	0.01	0.00	0.00	0.00
Net Income	-36.14	-31.63	-12.65	-9.67	-5.75
Net Income - Continuous Operations	-36.14	-31.63	-12.65	-9.67	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-39.83	-31.53	-12.76	-9.64	-5.73
EBIT	-40.00	-31.67	-12.82	-9.67	-5.74
Depreciation & Amortization	0.17	0.14	0.06	0.03	0.02
Earnings Per Share
Basic EPS	-1.00	-1.00	-1.00	-	-1.00
Diluted EPS	-1.00	-1.00	-1.00	-	-1.00
Basic Shares Outstanding	30.54	26.59	19.98	24.10	8.79
Diluted Shares Outstanding	30.54	26.59	19.98	24.10	8.79